it becomes a self-fulfilling prophecy on here if everyone keeps saying the share price isn't going to go anywhere. It's mostly retail held and if everyone persuades each other to sell down on here, they will.
Personally I think as a double approved product company, OCC is ridiculously undervalued and Insto's will now get on board as CelGro Nerve has massive global revenue potential, far greater than CelGro Bone. Always been a long term hold and build for me.
With respect Hotdog it wasn't long ago you were berating everyone on here for having weak hands. OCC just got TGA approval that sets an excellent platform for FDA approval as it did in CelGro Bone, as well as organic Australian revenue growth.
Ann: Trading Halt, page-94
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
-0.005(1.25%) |
Mkt cap ! $82.68M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.0¢ | 39.0¢ | $54.39K | 137.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2298 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 193037 | 5 |
View Market Depth
| Last trade - 12.41pm 12/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |